Healthcare Portal Investment Opportunity in Atlanta, USA
Transforming healthcare into proactive wellness using biological big-data and AI via a global SaaS platform.
Premium Plan
| Established | 0-1 year(s) |
| Employees | 5 - 10 |
| Legal Entity | Limited Liability Company (LLC) |
| Reported Sales | Nil |
| Run Rate Sales | Nil |
| EBITDA Margin | Nil |
| Industries | Healthcare Portal |
| Locations | Atlanta |
| Local Time | 12:17 AM America / New York |
| Listed By | Business Owner / Director |
| Status | Active |
Partial Stake Sale
USD
5 million
for
25.0%
stake
(Native Currency: USD 5,000,000)
Reason: Seeking investment to support product deployment and drive international expansion.
Name, Phone, Email
Not disclosed
Business Name
Not disclosed
User Verification
Business Overview
- Based in Atlanta, this pioneering biotech startup leverages 15 years of founders' industry experience to drive proactive wellness through advanced healthcare analytics, currently in pre-revenue stage.
- With a focus on precision medicine, the company has amassed and analyzed multiomic data from close to 10,000 participants, paving the way for individualized healthcare strategies that aim to maximize healthy lifespans.
- The cutting-edge biological Big Data technology created by this global entity allows for detailed individual lifestyle and health analysis, essential for transforming national healthcare systems.
- The product and the tech are ready and poised to deploy the innovative SaaS product using a flexible subscription model, ready for adoption in the US, and select European and Middle Eastern markets.
- By integrating multiomic biological data and artificial intelligence, the company offers a unique, comprehensive view of patient health at various life stages, positioning itself at the forefront of the wellness revolution.
- The organization’s proprietary technology, proven effective in past ventures such as G3, B4X, and PUER, transforms population health by promoting prevention and wellness on a global scale.
- As a SaaS company, its subscription-based model is designed to make cutting-edge healthcare solutions accessible, aiming to reduce overall healthcare costs while enhancing the quality of life worldwide.
- With a focus on precision medicine, the company has amassed and analyzed multiomic data from close to 10,000 participants, paving the way for individualized healthcare strategies that aim to maximize healthy lifespans.
- The cutting-edge biological Big Data technology created by this global entity allows for detailed individual lifestyle and health analysis, essential for transforming national healthcare systems.
- The product and the tech are ready and poised to deploy the innovative SaaS product using a flexible subscription model, ready for adoption in the US, and select European and Middle Eastern markets.
- By integrating multiomic biological data and artificial intelligence, the company offers a unique, comprehensive view of patient health at various life stages, positioning itself at the forefront of the wellness revolution.
- The organization’s proprietary technology, proven effective in past ventures such as G3, B4X, and PUER, transforms population health by promoting prevention and wellness on a global scale.
- As a SaaS company, its subscription-based model is designed to make cutting-edge healthcare solutions accessible, aiming to reduce overall healthcare costs while enhancing the quality of life worldwide.
Products & Services Overview
A revolutionary SaaS solution that integrates advanced multiomic data analysis and AI into healthcare systems, enabling early detection and prevention of chronic diseases to reduce costs and improve outcomes. Its platform is designed for use by healthcare systems, hospitals, clinics, and providers to enhance diagnostic accuracy, personalize treatment plans, and shift care models from reactive to preventative. By addressing preventable chronic disease management and minimizing misdiagnosis through precision medicine, the company empowers institutions to improve patient care while reducing long-term healthcare expenditures.
Assets Overview
The business doesn't have physical assets of significant value.The IP and proprietary know-how are valued at USD 20 million.
Facilities Overview
We operate from a small rented office in Atlanta, Georgia, supported by a virtual team across multiple countries.
Capitalization Overview
Self-funded.Typical biotech investors in the ecosystem are required to develop core technology.
There are 3 partners in the business.
No outstanding loans.
Recent Activity
-
Earlier than 15 daysDirector, Real Estate Consultancy And Investment, Lisbon, Corporate Investor / Buyer connected with the Business
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
2 Investors already contacted this Business.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 63,500+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses